New England Takes $8.4 Billion Slice of Pharmaceutical-Biotech Capital/MRO Investment Pie
Attachment: New England Pharma-Biotech Projects, Sep 2014
SUGAR LAND--September 10, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--There are nearly 1,350 active Pharmaceutical-Biotech Industry capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of $61 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the New England region is at the top, accounting for an $8.4 billion portion of that spending for 126 projects.
Within this article: Details on projects from leading companies, such as Novartis (NYSE:NVS), The Jackson Laboratory and Gilbane, including investment values and schedules.
